Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”), today reported financial results for the fourth quarter and full year ended December 31, 2023.
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”), today reported financial results for the fourth quarter and full year ended December 31, 2023.